The document provides a list of cancer drugs approved by the FDA specifically for bone cancer, along with their generic and brand names. It includes links to more detailed information about each drug on the National Cancer Institute's website. Additionally, it notes that there may be other drugs used for bone cancer that are not included in this list.

1. National Cancer Institute at the National Institutes of Health
Updated: 08/02/2013
Drugs Approved for Bone Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for bone cancer. The list
includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries.
There may be drugs used in bone cancer that are not listed here.
Abitrexate (Methotrexate)
Adriamycin PFS (Doxorubicin Hydrochloride)
Adriamycin RDF (Doxorubicin Hydrochloride)
Doxorubicin Hydrochloride
Folex (Methotrexate)
Folex PFS (Methotrexate)
Methotrexate
Methotrexate LPF (Methotrexate)
Mexate (Methotrexate)
Mexate-AQ (Methotrexate)
Cancer Drug Information
Drugs Approved for Bone Cancer - National Cancer Institute http://www.cancer.gov/cancertopics/druginfo/bonecancer/print
1 of 1 5/12/2014 3:54 AM